论文部分内容阅读
基于Ⅰ型变态反应参与EHF发病过程的新学说,作者选用赛庚啶治疗EHF早期病人,取得一定疗效。根据1981年全国修订诊断标准,择发病2～5病日内,间接免疫莹光检测阳性的发热期病例,随机分为54例治疗组和62例对照组。对照组常规用平衡盐综合液体疗法,治疗组在液体疗法基础上加用赛庚啶,每日3次,每次4毫克,疗程5天。尽管入院时治疗组发热程度较对
Based on the new theory of the involvement of type I allergic reaction in the pathogenesis of EHF, the authors selected cyproheptadine to treat early EHF patients and achieved a certain effect. According to the national revised diagnostic criteria in 1981, cases of fever during indirect immunofluorescence test were randomly divided into treatment group (54 cases) and control group (62 cases). Control group conventional balanced salt synthesis liquid therapy, the treatment group on the basis of liquid therapy plus cyproheptadine, 3 times a day, each 4 mg, for 5 days. Although the treatment group on admission than the fever